| Characterizing poliovirus transmission and evolution: Insights from modeling experiences with wild and vaccine‐related polioviruses RJ Duintjer Tebbens, MA Pallansch, DA Kalkowska, SGF Wassilak, ... Risk Analysis 33 (4), 703-749, 2013 | 103 | 2013 |
| Modeling options to manage type 1 wild poliovirus imported into Israel in 2013 DA Kalkowska, RJ Duintjer Tebbens, I Grotto, LM Shulman, E Anis, ... The Journal of infectious diseases 211 (11), 1800-1812, 2015 | 67 | 2015 |
| Modeling undetected live poliovirus circulation after apparent interruption of transmission: Implications for surveillance and vaccination DA Kalkowska, RJ Duintjer Tebbens, MA Pallansch, SL Cochi, ... BMC infectious diseases 15, 1-12, 2015 | 60 | 2015 |
| The potential impact of expanding target age groups for polio immunization campaigns RJ Duintjer Tebbens, DA Kalkowska, SGF Wassilak, MA Pallansch, ... BMC Infectious Diseases 14, 1-17, 2014 | 60 | 2014 |
| Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication KM Thompson, DA Kalkowska Expert Review of Vaccines 19 (7), 661-686, 2020 | 46 | 2020 |
| Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria DA Kalkowska, RJ Duintjer Tebbens, KM Thompson The Journal of Infectious Diseases 210 (suppl_1), S412-S423, 2014 | 45 | 2014 |
| Global transmission of live polioviruses: updated dynamic modeling of the polio endgame DA Kalkowska, MA Pallansch, SGF Wassilak, SL Cochi, KM Thompson Risk Analysis 41 (2), 248-265, 2021 | 44 | 2021 |
| Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India DA Kalkowska, RJ Duintjer Tebbens, KM Thompson The Journal of Infectious Diseases 210 (suppl_1), S398-S411, 2014 | 43 | 2014 |
| Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses KM Thompson, DA Kalkowska, RJD Tebbens Vaccine 33 (13), 1568-1577, 2015 | 40 | 2015 |
| Associations between pneumonia and residential distance to livestock farms over a five-year period in a large population-based study DA Kalkowska, GJ Boender, LAM Smit, C Baliatsas, J Yzermans, ... PLoS One 13 (7), e0200813, 2018 | 38 | 2018 |
| Updated characterization of outbreak response strategies for 2019–2029: impacts of using a novel type 2 oral poliovirus vaccine strain DA Kalkowska, MA Pallansch, A Wilkinson, AS Bandyopadhyay, ... Risk Analysis 41 (2), 329-348, 2021 | 37 | 2021 |
| Updated characterization of post‐OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart DA Kalkowska, MA Pallansch, SL Cochi, SD Kovacs, SGF Wassilak, ... Risk Analysis 41 (2), 320-328, 2021 | 31 | 2021 |
| The impact of disruptions caused by the COVID-19 pandemic on global polio eradication DA Kalkowska, A Voorman, MA Pallansch, SGF Wassilak, SL Cochi, ... Vaccine 41, A12-A18, 2023 | 30 | 2023 |
| The probability of undetected wild poliovirus circulation after apparent global interruption of transmission DA Kalkowska, RJ Duintjer Tebbens, KM Thompson American Journal of Epidemiology 175 (9), 936-949, 2012 | 29 | 2012 |
| Reflections on modeling poliovirus transmission and the polio eradication endgame KM Thompson, DA Kalkowska Risk Analysis 41 (2), 229-247, 2021 | 28 | 2021 |
| An updated economic analysis of the Global Polio Eradication Initiative KM Thompson, DA Kalkowska Risk Analysis 41 (2), 393-406, 2021 | 25 | 2021 |
| A health economic analysis for oral poliovirus vaccine to prevent COVID‐19 in the United States KM Thompson, DA Kalkowska, K Badizadegan Risk Analysis 41 (2), 376-386, 2021 | 24 | 2021 |
| Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV) KM Thompson, DA Kalkowska Expert Review of Vaccines 18 (7), 725-736, 2019 | 22 | 2019 |
| Potential future use, costs, and value of poliovirus vaccines KM Thompson, DA Kalkowska Risk Analysis 41 (2), 349-363, 2021 | 21 | 2021 |
| Modeling undetected live poliovirus circulation after apparent interruption of transmission: Pakistan and Afghanistan DA Kalkowska, RJ Duintjer Tebbens, MA Pallansch, KM Thompson Risk Analysis 39 (2), 402-413, 2019 | 21 | 2019 |
Kimberly M. ThompsonPresident, Kid Risk, Inc.Verified email at kidrisk.org
